The wide range of biological processes and functions that benzimidazole moieties can be used for makes them very interesting synthetic molecules. A novel class of scaffolds for benzimidazole heterocycles has been successfully constructed in the present study and synthesized by using the starting material of O-phenylenediamine derivatives (1a–c). The 1-methyl-2-(methylthio)-1H-benzo[d]imidazole derivatives (3a–c) have been synthesized as intermediate compounds by treating the precursors (1a–c) with carbon disulfide followed by N- and S-methylation with iodomethane and anhydrous potassium carbonate. In the latter step, the intermediate molecules were converted into benzimidazole-containing methyl-piperazine (4a–c), piperazin-ol tethered benzimidazoles (5a–c), and phenylpiperazine holding benzimidazoles (6a–c). The structures assigned to target compounds have been analyzed and confirmed via IR, NMR, and MS analysis. The antibacterial, anthelmintic, and anticancer properties of the target compounds were examined. The biological study showed that the compounds 6b, 4c, and 5a emerge as excellent antibacterial, antifungal, and anthelmintic agents, respectively, whereas heterocycle 6a showed excellent anticancer activity against hepatocyte-derived cell line HUH7, as well as the MCF7 breast cancer cell line with IC50 values of 6.41 and 9.70 µg/mL, respectively. The discovery of a novel class of hetero compounds with multiple hetero moieties that may aid in medication design is also highlighted in this study.
A novel class of hybrid compounds, such as thiadiazolyl-pyrazoles (14a-e) and benzothiazolyl-pyrazoles (15a-d), has been successfully synthesized via a simple condensation reaction. Newly synthesized compounds have been characterized by mass, 1H, and 13C NMR spectral analysis. The target compounds have been studied for their DFT docking, antibacterial, antioxidant, and cytotoxicity properties. Among the target compounds, heterocycle 14e showed significant binding with penicillin G acyl-Penicillin (1MWT) and Escherichia coli DNA gyrase B (6KZX) protein target, with binding scores -6.5 and -8.2 kcal/mol, respectively. In addition, the compounds 14c and 14e showed superior activity against both the microbes at different concentrations, whereas compounds 14a and 14e showed excellent antioxidant activity at 100 µg/mL concentration. Among the selected compounds, heterocycle 14e exhibited significant anticancer activity against both triple-negative breast cancer (MDA-MB-231) and oestrogen receptor-positive breast cancer (MCF-7) cell lines, with 68.49 and 57.38% of inhibition, respectively.